|
|
|
|
| LEADER |
00000cam a2200000Ii 4500 |
| 001 |
SCIDIR_ocn893722529 |
| 003 |
OCoLC |
| 005 |
20231120111833.0 |
| 006 |
m o d |
| 007 |
cr cnu---unuuu |
| 008 |
141025s1985 flua ob 001 0 eng d |
| 040 |
|
|
|a OPELS
|b eng
|e rda
|e pn
|c OPELS
|d N$T
|d E7B
|d S4S
|d EBLCP
|d DEBSZ
|d OCLCQ
|d OCLCO
|d MERUC
|d OCLCQ
|d OCLCA
|d OCL
|d OCLCQ
|d VLY
|d OCLCO
|d OCLCQ
|d OCLCO
|
| 019 |
|
|
|a 897643616
|a 1162418926
|
| 020 |
|
|
|a 9781483273686
|q (electronic bk.)
|
| 020 |
|
|
|a 1483273687
|q (electronic bk.)
|
| 020 |
|
|
|z 0121852024
|
| 020 |
|
|
|z 9780121852023
|
| 035 |
|
|
|a (OCoLC)893722529
|z (OCoLC)897643616
|z (OCoLC)1162418926
|
| 050 |
|
4 |
|a QH603.C43
|b R428 1985eb
|
| 072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 615.7
|2 23
|
| 245 |
0 |
4 |
|a The receptors.
|n Volume II /
|c edited by P. Michael Conn, Department of Pharmacology, University of Iowa, College of Medicine, Iowa City, Iowa.
|
| 264 |
|
1 |
|a Orlando :
|b Academic Press, Inc. (Harcourt Brace Jovanovich, Publishers,
|c 1985.
|
| 300 |
|
|
|a 1 online resource (xvi, 436 pages) :
|b illustrations
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a Front Cover; The Receptors; Copyright Page; Table of Contents; Contributors; Preface; Contents of Previous Volume; CHAPTER 1. The Vitamin D Receptor; I. Introduction; II. Discovery of the Receptor Proteins for 1,25-(OH)2D3; III. Biochemical and Physical Properties of the 1,25-(OH)2D3 Receptor; IV. Mechanism of Action of the 1,25-(OH)2D3 Receptor; V. Regulation of Receptor Number; VI. Purification of Chick Intestinal 1,25-(OH)2D3 Receptor; VII. Antibodies to Chick Intestinal 1,25-(OH)2D3 Receptor; VIII. Conclusions; References
|
| 505 |
8 |
|
|a CHAPTER 2. On Experimental Discrimination between Alternative Mechanistic Models for the Receptor-Mediated Stimulation of Adenylate CyclaseI. Introduction; II. General Assumptions, Definitions, and Nomenclature; III. Is the Receptor a Catalyst or a Reactant?; IV. What Are the Functional Relationships between R, N, and C, and How Are They Affected by Agonist and Guanine Nucleotide?; V. Summary; References; CHAPTER 3. The Role of Microaggregation in Hormone-Receptor-Effector Interactions; I. Introduction; II. The GnRH Receptor
|
| 505 |
8 |
|
|a III. Evidence That Microaggregation Plays a Key Role in Other Antibody-Receptor-Effector SystemsIV. The Adenylate Cyclase System; V. Receptor-Effector Interactions Revisited; References; CHAPTER 4. The Ah Receptor: A Biochemical and Biologic Perspective; I. Introduction; II. Biochemical Characterization of the Ah Receptor; III. Biology of the Ah Receptor; IV. Mechanism(s) of Action: Cell Biology and Biochemical Approaches; V. Concluding Comments; References; CHAPTER 5. Interactions of Animal Viruses with Cell Surface Receptors; I. Introduction; II. Viral Attachment Proteins
|
| 505 |
8 |
|
|a III. Identification of Cell Surface ReceptorsIV. Cell Surface Receptor Determinants of Animal Viruses; V. Role of Receptors in Viral Penetration; VI. Role of Viral Receptors in Host Range and Tissue Tropism; VII. Summary and Future Perspectives; References; CHAPTER 6. Studies on Insulin Receptors: Implications for Insulin Action; I. Introduction; II. Receptor Purification; III. Receptor Structure; IV. Glycoprotein Nature of the Insulin Receptor; V. Tyrosyl Phosphorylation; VI. Interrelations of the Insulin Receptor to Other Receptor Structures
|
| 505 |
8 |
|
|a VII. Receptor-Mediated Internalization and Degradation of InsulinVIII. Down-Regulation; IX. Possible Involvement of Cytoskeletal Elements in Insulin Action; X. Receptor Valence; XI. Nonlinear Scatchard Plots; XII. Possible Role for Receptor Cross-Linking and for Non-Insulin-Binding Regulatory Glycoprotein; XIII. Transmembrane Signaling; References; CHAPTER 7. Size of Neurotransmitter Receptors as Determined by Radiation Inactivation-Target Size Analysis; I. Introduction; II. Radiation Inactivation-Target Size Analysis; III. Conclusions and Avenues for Further Study; References
|
| 546 |
|
|
|a English.
|
| 650 |
|
0 |
|a Cell receptors.
|
| 650 |
|
0 |
|a Drug receptors.
|
| 650 |
|
0 |
|a Binding sites (Biochemistry)
|
| 650 |
|
2 |
|a Receptors, Cell Surface
|0 (DNLM)D011956
|
| 650 |
|
2 |
|a Receptors, Drug
|0 (DNLM)D011955
|
| 650 |
|
2 |
|a Binding Sites
|0 (DNLM)D001665
|
| 650 |
|
6 |
|a R�ecepteurs cellulaires.
|0 (CaQQLa)201-0010863
|
| 650 |
|
6 |
|a R�ecepteurs de m�edicaments.
|0 (CaQQLa)201-0010864
|
| 650 |
|
6 |
|a Sites actifs (Biochimie)
|0 (CaQQLa)201-0010862
|
| 650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
| 650 |
|
7 |
|a Drug receptors
|2 fast
|0 (OCoLC)fst00898699
|
| 650 |
|
7 |
|a Binding sites (Biochemistry)
|2 fast
|0 (OCoLC)fst00831875
|
| 650 |
|
7 |
|a Cell receptors
|2 fast
|0 (OCoLC)fst00850227
|
| 700 |
1 |
|
|a Conn, P. Michael,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|t Receptors. Vol. 2
|z 0121852024
|w (OCoLC)271221148
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780121852023
|z Texto completo
|
